{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:36:57Z","timestamp":1765233417416,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.repc.2021.09.018","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T08:30:52Z","timestamp":1663921852000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glycoprotein IIb\/IIIa inhibitor use in cardiogenic shock complicating myocardial infarction: The Portuguese Registry of Acute Coronary Syndromes"],"prefix":"10.1016","volume":"42","author":[{"given":"Carolina","family":"Saleiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Puga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 P.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita M.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandrina","family":"Siserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lino","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2021.09.018_bib0125","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/eurheartj\/ehs264","article-title":"Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French Nationwide Registries","volume":"33","author":"Aissaoui","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2021.09.018_bib0130","first-page":"16","article-title":"Contemporary trends in cardiogenic shock: incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group","volume":"7","author":"Rathod","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.repc.2021.09.018_bib0135","first-page":"341","article-title":"Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction","volume":"9","author":"Wayangankar","year":"2016","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.repc.2021.09.018_bib0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0735-1097(20)30745-2","article-title":"Acute and stable ischemic heart disease","volume":"75","author":"Omer","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2021.09.018_bib0145","first-page":"183","volume":"9","author":"Zeymer","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.repc.2021.09.018_bib0150","first-page":"1576","article-title":"Routine glycoprotein IIb\/IIIa inhibitor therapy in ST-segment elevation myocardial infarction: a meta-analysis","volume":"35","author":"Karathanos","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.repc.2021.09.018_bib0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2021.09.018_bib0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjcard.2005.02.040","article-title":"Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model","volume":"96","author":"Klein","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2021.09.018_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(01)02187-7","article-title":"Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock","volume":"89","author":"Giri","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2021.09.018_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(01)02188-9","article-title":"Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction","volume":"89","author":"Chan","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2021.09.018_bib0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0002-9149(02)02487-6","article-title":"Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation","volume":"90","author":"Antoniucci","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2021.09.018_bib0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0735-1097(00)00814-7","article-title":"Platelet glycoprotein IIb\/IIIa blockage and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation","volume":"38","author":"Hasdai","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2021.09.018_bib0185","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/17482941.2011.567282","article-title":"Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: the PRAGUE-7 Study. An open randomized multicentre study","author":"Tousek","year":"2011","journal-title":"Acute Card Care"},{"key":"10.1016\/j.repc.2021.09.018_bib0190","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1253\/circj.CJ-15-0053","article-title":"Effect of abciximab therapy in patients undergoing coronary angioplasty for acute ST-elevation myocardial infarction complicated by cardiogenic shock","volume":"79","author":"De Felice","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.repc.2021.09.018_bib0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.hlc.2017.02.011","article-title":"GPIIb-IIIa receptor inhibitors in acute coronary syndrome patients presenting with cardiogenic shock and\/or after cardiopulmonary resuscitation","volume":"27","author":"Kanic","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.repc.2021.09.018_bib0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ahj.2013.01.012","article-title":"Early and late outcomes after primary percutaneous coronary intervention by radial or femoral approach in patients presenting in acute ST-elevation myocardial infarction and cardiogenic shock","volume":"165","author":"Bernat","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2021.09.018_bib0205","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2021.09.018_bib0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09537104.2018.1562171","article-title":"Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution","volume":"31","author":"Somaschini","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.repc.2021.09.018_bib0215","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jacc.2003.08.040","article-title":"Effects of glycoprotein IIb\/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study","volume":"43","author":"Kunichika","year":"2004","journal-title":"J Am Coll Cardiol"},{"journal-title":"Eur Heart J Cardiovasc Pharmacother","year":"2020","author":"Gorog","key":"10.1016\/j.repc.2021.09.018_bib0220"},{"key":"10.1016\/j.repc.2021.09.018_bib0225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40560-020-00502-y","article-title":"Glycoprotein IIb\/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression","volume":"8","author":"Saleiro","year":"2020","journal-title":"J Intensive Care"},{"key":"10.1016\/j.repc.2021.09.018_bib0230","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0039-1700546","article-title":"Efficacy and safety of glycoprotein IIb\/IIIa inhibitors on top of ticagrelor in STEMI: a subanalysis of the ATLANTIC Trial","volume":"120","author":"Tavenier","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.repc.2021.09.018_bib0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.resuscitation.2019.02.008","article-title":"Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: a global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trial","volume":"137","author":"Droppa","year":"2019","journal-title":"Resuscitation"},{"key":"10.1016\/j.repc.2021.09.018_bib0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.120.046928","article-title":"Cangrelor, tirofiban and chewed or standard prasugrel regimens in patients with ST-segment-elevation myocardial infarction: primary results of the FABOLUS FASTER Trial","volume":"142","author":"Gargiulo","year":"2020","journal-title":"Circulation"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S087025512200364X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S087025512200364X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:12:50Z","timestamp":1760109170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S087025512200364X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S087025512200364X"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2021.09.018","relation":{},"ISSN":["0870-2551"],"issn-type":[{"type":"print","value":"0870-2551"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoprotein IIb\/IIIa inhibitor use in cardiogenic shock complicating myocardial infarction: The Portuguese Registry of Acute Coronary Syndromes","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2021.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}